s-adenosylmethionine has been researched along with Carcinogenesis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 9 (64.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, H; Chen, P; Chen, Y; Fan, X; Gonzalez, FJ; Huang, M; Huang, P; Ou, T; Wang, L; Wang, S; Wang, Y; Yu, A; Yu, T; Zhang, H; Zhou, X; Zhou, Y | 1 |
| Duan, S; Qi, Y; Zhang, M; Zhang, Q; Zhong, C | 1 |
| Calvisi, DF; Feo, CF; Feo, F; Pascale, RM; Simile, MM | 1 |
| Buettner, R; Guo, J; Rosen, ST; Yang, Y | 1 |
| Arakelian, A; Attias, M; Mehdi, A; Piccirillo, CA; Rabbani, SA; Szyf, M | 1 |
| Battaglia-Hsu, SF; Chen, B; Feng, J; Gong, C; Guo, D; Guo, T; Li, Z; Liu, P; Liu, Z; Wang, H; Wu, P; Xiao, Y; Yao, Y | 1 |
| Chen, Y; Fan, W; Li, M; Li, TWH; Li, Y; Liu, T; Lu, L; Lu, SC; Mato, JM; Peng, H; Seki, E; Steggerda, J; Tu, J; Wang, J; Xiong, T; Yang, H; Zhang, J; Zhou, ZG | 1 |
| Budhu, A; Chaisaingmongkol, J; Chang, CW; Diggs, LP; Forgues, M; Greten, TF; Heinrich, S; Hung, MH; Lee, JS; Ma, C; Ma, L; Ruchirawat, M; Ruppin, E; Wang, XW | 1 |
| Chi, YI; De Assuncao, TM; Dsouza, NR; Leverence, EN; Lomberk, G; Mathison, AJ; Smith, BC; Stodola, TJ; Tripathi, S; Urrutia, R; Volkman, BF; Zimmermann, MT | 1 |
| Dobrota, D; Hatok, J; Kowtharapu, BS; Murín, R; Vidomanová, E | 1 |
| Cao, Y; Gao, M; He, Y; Liu, S; Tang, H; Tao, Y | 1 |
| Arrowsmith, CH; Brown, PJ; Dong, A; Duan, S; He, H; Li, F; Schapira, M; Seitova, A; Senisterra, G; Vedadi, M; Wu, H; Zeng, H | 1 |
| Da, MX; Duan, YX; Yao, JB; Zhang, YB | 1 |
| Hwang, PH; Lian, L; Zavras, AI | 1 |
5 review(s) available for s-adenosylmethionine and Carcinogenesis
| Article | Year |
|---|---|
LINC00662: A new oncogenic lncRNA with great potential.
Topics: Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; MicroRNAs; Oncogenes; RNA, Long Noncoding; S-Adenosylmethionine; Wnt Signaling Pathway | 2022 |
S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent.
Topics: Animals; Antiviral Agents; Betaine; Carcinogenesis; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Colorectal Neoplasms; Humans; Liver Neoplasms; Male; Methionine Adenosyltransferase; Non-alcoholic Fatty Liver Disease; Rats; Ribavirin; S-Adenosylmethionine | 2022 |
Targeting the methionine-methionine adenosyl transferase 2A- S -adenosyl methionine axis for cancer therapy.
Topics: Animals; Carcinogenesis; Humans; Mammals; Methionine; Methionine Adenosyltransferase; Neoplasms; S-Adenosylmethionine | 2022 |
Role of S-adenosylmethionine cycle in carcinogenesis.
Topics: Animals; Carcinogenesis; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Models, Genetic; Neoplasms; S-Adenosylmethionine; Signal Transduction | 2017 |
Metabolic Intermediates in Tumorigenesis and Progression.
Topics: Acetyl Coenzyme A; Antineoplastic Agents; Carcinogenesis; Cell Proliferation; Disease Progression; Flavin-Adenine Dinucleotide; Humans; NAD; Neoplasm Invasiveness; Neoplasms; S-Adenosylmethionine; Tetrahydrofolates | 2019 |
9 other study(ies) available for s-adenosylmethionine and Carcinogenesis
| Article | Year |
|---|---|
Carnitine palmitoyltransferase 1C contributes to progressive cellular senescence.
Topics: Animals; Carcinogenesis; Carcinoma; Carnitine; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; DNA-Binding Proteins; Gene Expression Regulation; Genetic Vectors; Humans; Male; Metabolomics; Mice; Mitochondria; Mitochondrial Proteins; Mitophagy; Neoplasm Transplantation; Nuclear Respiratory Factor 1; Pancreatic Neoplasms; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR alpha; Protein Transport; RNA, Messenger; Signal Transduction; Telomere Shortening; Transcription Factors; Tumor Suppressor Proteins | 2020 |
S-adenosylmethionine blocks tumorigenesis and with immune checkpoint inhibitor enhances anti-cancer efficacy against BRAF mutant and wildtype melanomas.
Topics: Animals; Carcinogenesis; CD8-Positive T-Lymphocytes; Cell Transformation, Neoplastic; Immune Checkpoint Inhibitors; Melanoma; Mice; Proto-Oncogene Proteins B-raf; S-Adenosylmethionine | 2023 |
LINC00662 promotes hepatocellular carcinoma progression via altering genomic methylation profiles.
Topics: 3' Untranslated Regions; 5-Methylcytosine; Adenosylhomocysteinase; Adult; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Progression; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Genome, Human; Humans; Liver Neoplasms; Methionine Adenosyltransferase; Proteolysis; RNA, Long Noncoding; RNA, Messenger; S-Adenosylhomocysteine; S-Adenosylmethionine; Survival Analysis; Ubiquitin; Up-Regulation | 2020 |
Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer.
Topics: Animals; Carcinogenesis; Cell Line, Tumor; Datasets as Topic; Feedback, Physiological; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; Hepatocytes; Humans; Hydrocarbons, Fluorinated; Liver; Liver Neoplasms; Male; Methionine Adenosyltransferase; Mice; Mice, Knockout; NF-kappa B; Primary Cell Culture; Promoter Regions, Genetic; Pyridines; S-Adenosylmethionine; Sulfonamides; Thiophenes; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2020 |
Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma.
Topics: Animals; Biomarkers, Tumor; Carcinogenesis; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Cell Line, Tumor; CRISPR-Cas Systems; Female; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Humans; Liver; Liver Neoplasms; Methionine; Methionine Adenosyltransferase; Mice; Mice, Inbred C57BL; Mice, Knockout; S-Adenosylmethionine; T-Lymphocytes; Transcriptome | 2021 |
Computational modeling reveals key molecular properties and dynamic behavior of disruptor of telomeric silencing 1-like (DOT1L) and partnering complexes involved in leukemogenesis.
Topics: Carcinogenesis; Histone-Lysine N-Methyltransferase; Humans; Leukemia; Molecular Dynamics Simulation; Nucleosomes; Oncogene Proteins, Fusion; S-Adenosylmethionine | 2022 |
Structure of the catalytic domain of EZH2 reveals conformational plasticity in cofactor and substrate binding sites and explains oncogenic mutations.
Topics: Amino Acid Sequence; Animals; Carcinogenesis; Catalytic Domain; Coenzymes; Crystallography, X-Ray; Enhancer of Zeste Homolog 2 Protein; Enzyme Activation; Humans; Lymphoma; Mice; Models, Molecular; Molecular Sequence Data; Mutation; Polycomb Repressive Complex 2; Protein Binding; Recurrence; S-Adenosylmethionine | 2013 |
DNA methylation regulates expression of VEGF-C, and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinogenesis; Cell Line, Tumor; DNA Methylation; Down-Regulation; Flow Cytometry; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Immunohistochemistry; Male; Mice, Nude; Oncogenes; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; RNA, Messenger; S-Adenosylmethionine; Stomach Neoplasms; Vascular Endothelial Growth Factor C | 2014 |
Alcohol intake and folate antagonism via CYP2E1 and ALDH1: effects on oral carcinogenesis.
Topics: Alcohol Drinking; Aldehyde Dehydrogenase 1 Family; Carcinogenesis; Cytochrome P-450 CYP2E1; DNA; Ethanol; Folic Acid Antagonists; Folic Acid Deficiency; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Humans; Isoenzymes; Mouth Neoplasms; Nucleotides; Retinal Dehydrogenase; Risk; S-Adenosylmethionine | 2012 |